$1.52 Billion is the total value of Bellevue Group AG's 138 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 15.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ILMN | Buy | ILLUMINA INC | $75,550,000 | +39.3% | 251,893 | +70.5% | 4.97% | +44.4% |
| ABT | Buy | ABBOTT LABS | $70,627,000 | +25.6% | 976,451 | +27.4% | 4.64% | +30.2% |
| New | ISHARES TR NASDAQ BIOTECH | $70,000,000 | – | 200 | +100.0% | 4.60% | – | |
| ISRG | Buy | INTUITIVE SURGICAL INC | $66,473,000 | +31.8% | 138,797 | +58.0% | 4.37% | +36.6% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $65,090,000 | +13.7% | 310,795 | +112.4% | 4.28% | +17.9% |
| ANTM | Buy | ANTHEM INC | $61,103,000 | -0.5% | 232,660 | +3.8% | 4.02% | +3.1% |
| TDOC | Buy | TELADOC HEALTH INC | $53,230,000 | +5.1% | 1,073,839 | +83.1% | 3.50% | +8.9% |
| CELG | Buy | CELGENE CORP | $42,146,000 | -22.3% | 657,601 | +8.5% | 2.77% | -19.4% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $37,350,000 | -0.9% | 1,056,889 | +8.0% | 2.46% | +2.7% |
| DHR | Buy | DANAHER CORP DEL | $34,328,000 | +24.9% | 332,896 | +31.6% | 2.26% | +29.4% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $33,092,000 | +0.4% | 132,836 | +7.3% | 2.18% | +4.1% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $32,310,000 | -10.1% | 260,648 | +21.9% | 2.12% | -6.8% |
| BDX | Buy | BECTON DICKINSON & CO | $27,460,000 | -0.2% | 121,872 | +15.6% | 1.80% | +3.4% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $25,305,000 | +19.3% | 486,824 | +42.5% | 1.66% | +23.6% |
| SYK | Buy | STRYKER CORP | $23,643,000 | -5.9% | 150,834 | +6.7% | 1.55% | -2.4% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NEW | $20,791,000 | +19.6% | 451,972 | +15.3% | 1.37% | +23.9% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $20,683,000 | +29.1% | 382,588 | +23.2% | 1.36% | +33.9% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $19,644,000 | +116.8% | 83,204 | +194.3% | 1.29% | +124.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $19,007,000 | +143.5% | 114,700 | +183.3% | 1.25% | +152.5% |
| WMGI | Buy | WRIGHT MED GROUP NV | $18,458,000 | +2.1% | 678,114 | +8.9% | 1.21% | +5.9% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $18,359,000 | -16.7% | 246,762 | +3.3% | 1.21% | -13.6% |
| HRC | Buy | HILL ROM HLDGS INC | $18,153,000 | +3.6% | 205,008 | +10.4% | 1.19% | +7.4% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $16,360,000 | -15.0% | 224,385 | +2.0% | 1.08% | -11.9% |
| FIT | Buy | FITBIT INCcl a | $15,998,000 | +19.0% | 3,218,884 | +28.0% | 1.05% | +23.3% |
| QGEN | Buy | QIAGEN NV | $14,996,000 | +195.0% | 435,299 | +224.4% | 0.99% | +206.2% |
| AKCA | Buy | AKCEA THERAPEUTICS INC | $13,813,000 | -5.8% | 458,296 | +9.5% | 0.91% | -2.4% |
| MGNX | Buy | MACROGENICS INC | $13,551,000 | -12.7% | 1,066,993 | +47.3% | 0.89% | -9.5% |
| CDNA | Buy | CAREDX INC | $13,487,000 | +38.7% | 536,488 | +59.2% | 0.89% | +43.8% |
| ABMD | Buy | ABIOMED INC | $12,619,000 | -15.3% | 38,822 | +17.2% | 0.83% | -12.2% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $11,726,000 | +486.0% | 83,600 | +619.4% | 0.77% | +507.1% |
| LIVN | Buy | LIVANOVA PLC | $11,663,000 | -19.2% | 127,510 | +9.5% | 0.77% | -16.3% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $11,519,000 | -23.6% | 1,123,813 | +24.1% | 0.76% | -20.8% |
| INSM | Buy | INSMED INC | $10,616,000 | -7.3% | 809,146 | +42.9% | 0.70% | -3.9% |
| HCM | Buy | HUTCHISON CHINA MEDITECH LTDsponsored adr | $10,164,000 | -21.1% | 440,169 | +10.0% | 0.67% | -18.2% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $9,718,000 | -1.3% | 1,999,540 | +49.3% | 0.64% | +2.2% |
| DXCM | Buy | DEXCOM INC | $9,321,000 | -9.0% | 77,808 | +8.6% | 0.61% | -5.7% |
| AMGN | Buy | AMGEN INC | $8,750,000 | +14.2% | 44,950 | +21.7% | 0.58% | +18.3% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $8,586,000 | +153.7% | 261,210 | +370.5% | 0.56% | +162.8% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $8,211,000 | -2.4% | 36,692 | +6.4% | 0.54% | +1.1% |
| COO | Buy | COOPER COS INC | $7,538,000 | +19.2% | 29,619 | +29.8% | 0.50% | +23.7% |
| XENT | Buy | INTERSECT ENT INC | $6,691,000 | -0.6% | 237,444 | +1.4% | 0.44% | +3.0% |
| OMCL | Buy | OMNICELL INC | $6,616,000 | -12.1% | 108,042 | +3.2% | 0.44% | -8.8% |
| GMED | Buy | GLOBUS MED INCcl a | $6,623,000 | -22.9% | 153,031 | +1.2% | 0.44% | -20.2% |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $6,575,000 | -29.5% | 145,779 | +2.9% | 0.43% | -27.0% |
| MOH | Buy | MOLINA HEALTHCARE INC | $6,437,000 | -14.2% | 55,384 | +9.7% | 0.42% | -11.1% |
| QDEL | New | QUIDEL CORP | $6,103,000 | – | 125,000 | +100.0% | 0.40% | – |
| HCA | Buy | HCA HEALTHCARE INC | $5,853,000 | +14.0% | 47,034 | +27.5% | 0.38% | +18.1% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $5,822,000 | -11.7% | 83,792 | +20.3% | 0.38% | -8.4% |
| TRHC | Buy | TABULA RASA HEALTHCARE INC | $5,602,000 | -20.6% | 87,857 | +1.1% | 0.37% | -17.7% |
| TFX | Buy | TELEFLEX INC | $5,104,000 | +7.8% | 19,748 | +11.0% | 0.34% | +12.0% |
| QTNT | Buy | QUOTIENT LTD | $5,102,000 | -6.4% | 833,619 | +15.5% | 0.34% | -3.2% |
| MTLS | Buy | MATERIALISE NVsponsored ads | $4,310,000 | +48.2% | 215,192 | +2.1% | 0.28% | +53.8% |
| INGN | Buy | INOGEN INC | $4,134,000 | -27.2% | 33,292 | +43.1% | 0.27% | -24.4% |
| GH | New | GUARDANT HEALTH INC | $4,102,000 | – | 109,117 | +100.0% | 0.27% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $3,918,000 | +8.8% | 306,606 | +38.2% | 0.26% | +13.2% |
| INSP | Buy | INSPIRE MED SYS INC | $3,913,000 | +2.5% | 92,616 | +2.1% | 0.26% | +6.2% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $3,769,000 | -9.5% | 99,253 | +2.1% | 0.25% | -6.1% |
| INCY | Buy | INCYTE CORP | $3,730,000 | +3.2% | 58,650 | +12.0% | 0.24% | +7.0% |
| VEEV | Buy | VEEVA SYS INC | $3,402,000 | -4.4% | 38,092 | +16.5% | 0.22% | -0.9% |
| MDSO | Buy | MEDIDATA SOLUTIONS INC | $3,318,000 | +22.6% | 49,211 | +33.3% | 0.22% | +26.7% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $3,248,000 | -8.8% | 358,935 | +66.2% | 0.21% | -5.3% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $3,239,000 | +4.7% | 23,870 | +111.8% | 0.21% | +8.7% |
| STIM | Buy | NEURONETICS INC | $3,200,000 | -10.8% | 165,400 | +47.8% | 0.21% | -7.9% |
| NVRO | Buy | NEVRO CORP | $3,167,000 | -30.9% | 81,438 | +1.3% | 0.21% | -28.5% |
| PEN | Buy | PENUMBRA INC | $2,939,000 | +2.5% | 24,050 | +25.6% | 0.19% | +6.0% |
| MASI | Buy | MASIMO CORP | $2,446,000 | +0.8% | 22,780 | +17.0% | 0.16% | +4.5% |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $2,299,000 | -4.2% | 1,059,515 | +19.2% | 0.15% | -0.7% |
| AGN | Buy | ALLERGAN PLC | $2,139,000 | -13.6% | 16,000 | +23.1% | 0.14% | -10.2% |
| EXEL | New | EXELIXIS INC | $1,849,000 | – | 94,000 | +100.0% | 0.12% | – |
| CVS | Buy | CVS HEALTH CORP | $1,692,000 | +168.6% | 25,825 | +222.8% | 0.11% | +177.5% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $1,549,000 | +30.9% | 95,800 | +68.1% | 0.10% | +36.0% |
| FGEN | New | FIBROGEN INC | $1,481,000 | – | 32,000 | +100.0% | 0.10% | – |
| VCRA | New | VOCERA COMMUNICATONS INC | $1,297,000 | – | 32,950 | +100.0% | 0.08% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $1,280,000 | -23.1% | 12,900 | +13.2% | 0.08% | -20.8% |
| ARGX | New | ARGENX SEsponsored adr | $1,210,000 | – | 12,600 | +100.0% | 0.08% | – |
| LOXO | New | LOXO ONCOLOGY INC | $1,205,000 | – | 8,600 | +100.0% | 0.08% | – |
| MRK | Buy | MERCK & CO INC | $1,146,000 | +29.2% | 15,000 | +20.0% | 0.08% | +33.9% |
| MYGN | New | MYRIAD GENETICS INC | $927,000 | – | 31,900 | +100.0% | 0.06% | – |
| EVH | New | EVOLENT HEALTH INCcl a | $903,000 | – | 45,270 | +100.0% | 0.06% | – |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $754,000 | -5.0% | 131,135 | +124.0% | 0.05% | 0.0% |
| AFMD | New | AFFIMED N V | $529,000 | – | 170,000 | +100.0% | 0.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.